(Q44113629)

29 November 2017

title

Laboratory evaluation of rapid test kits to detect hepatitis C antibody for use in predonation screening in emergency settings (English)

1 reference

29 November 2017

1 reference

Christian T. Bautista

3

1 reference

29 November 2017

Mark M Manak

7

0 references

Susan L Stramer

13

object named as

Susan L Stramer

1 reference

29 November 2017

14

Nelson L Michael

1 reference

29 November 2017

Robert J O'Connell

1

1 reference

29 November 2017

Robert G Gates

2

1 reference

29 November 2017

Michelle Imbach

4

1 reference

29 November 2017

John C Eggleston

5

1 reference

29 November 2017

Stephen G Beardsley

6

1 reference

29 November 2017

Richard Gonzales

8

1 reference

29 November 2017

Francisco J Rentas

9

1 reference

29 November 2017

Victor W Macdonald

10

1 reference

29 November 2017

Lisa J Cardo

11

1 reference

29 November 2017

David T Reiber

12

1 reference

29 November 2017

Sheila A Peel

15

1 reference

29 November 2017

publication date

23 July 2012

1 reference

29 November 2017

1 reference

29 November 2017

volume

53

1 reference

29 November 2017

issue

3

1 reference

29 November 2017

page(s)

505-517

1 reference

Prevalence, incidence, and residual risk of major blood-borne infections among apheresis collections to the American Red Cross Blood Services, 2004 through 2008.

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03770.X

Pathogen inactivation: making decisions about new technologies. Report of a consensus conference

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03770.X

Transfusion-transmitted infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03770.X

Current incidence and residual risk of hepatitis B infection among blood donors in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03770.X

Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03770.X

Blood Transfusion Practices in Military Medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03770.X

Damage control resuscitation: a sensible approach to the exsanguinating surgical patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03770.X

Combat damage control surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03770.X

Massive transfusion and nonsurgical hemostatic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03770.X

Fresh whole blood transfusion: a controversial military practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03770.X

Trauma system development in a theater of war: Experiences from Operation Iraqi Freedom and Operation Enduring Freedom.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03770.X

Warm fresh whole blood transfusion for severe hemorrhage: U.S. military and potential civilian applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03770.X

Risks associated with fresh whole blood and red blood cell transfusions in a combat support hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03770.X

Fresh whole blood transfusions in coalition military, foreign national, and enemy combatant patients during Operation Iraqi Freedom at a U.S. combat support hospital.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03770.X

Prevalence and incidence of hepatitis C virus infection in the US military: a seroepidemiologic survey of 21,000 troops

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03770.X

The prevalence of hepatitis C virus infection in the United States, 1999 through 2002

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03770.X

Transfusion-transmissible viral infections among US military recipients of whole blood and platelets during Operation Enduring Freedom and Operation Iraqi Freedom

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03770.X

Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03770.X

Clinical outcomes after transfusion-associated hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03770.X

The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03770.X

American Gastroenterological Association technical review on the management of hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03770.X

Clinical Medical Research Award. Hepatitis C virus and eliminating post-transfusion hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03770.X

Predonation testing of potential blood donors in resource-restricted settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03770.X

Transfusion in sub-Saharan Africa: does a Western model fit?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03770.X

Predonation testing of potential blood donors in resource-restricted settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03770.X

Diagnosis, management, and treatment of hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03770.X

Human immunodeficiency virus testing for patient-based and population-based diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03770.X

Systematic reviews in health care: Systematic reviews of evaluations of diagnostic and screening tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03770.X

Users' guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Working Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03770.X

Evaluation of a new, rapid test for detecting HCV infection, suitable for use with blood or oral fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03770.X

Design of novel conformational and genotype-specific antigens for improving sensitivity of immunoassays for hepatitis C virus-specific antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03770.X

10.1111/J.1537-2995.2012.03770.X

21 January 2018

Identifiers

DOI

1 reference

29 November 2017

1 reference